Hyperion Biotechnology

Executive Summary

Hyperion Biotechnology is a privately held diagnostics company founded in 1998 and headquartered in San Antonio, Texas. The company operates at the intersection of biomarker discovery, human performance optimization, and environmental health, offering evidence-based solutions for healthcare, wellness, and operational environments. Its diversified business model encompasses biomarker research, applied diagnostics, human performance programs, and environmental laboratory services. By focusing on objective measurement and risk management, Hyperion aims to improve health outcomes and performance across multiple sectors, including military, industrial, and clinical settings. The company's long operating history suggests resilience, but its private status and lack of disclosed funding or valuation data limit external visibility into its financial trajectory and competitive positioning.

Upcoming Catalysts (preview)

• TBDLaunch of new biomarker-based diagnostic test60% success
• TBDStrategic partnership with military or aerospace organization for human performance program50% success
• TBDReceipt of SBIR/STTR grant for environmental health technology70% success